AUR-101 by Aurigene Oncology for Ankylosing Spondylitis (Bekhterev’s Disease): Likelihood of Approval

AUR-101 is under clinical development by Aurigene Oncology and currently in Phase II for Ankylosing Spondylitis (Bekhterev’s Disease).

Most Women Can Have Successful Pregnancies After Breast Cancer Treatment

CHICAGO — The vast majority of young breast cancer survivors who attempted pregnancy after treatment were able to become pregnant and have a live birth,

May 25, 2024

HEPA air purifiers fall short in cutting respiratory infections in aged-care facilities

Research on HEPA-14 air purifiers in aged care reveals no significant impact on respiratory infections, though initial phase results suggest potential benefits.

November 13, 2024

Waters launches XBridge Premier GTx BEH SEC columns for gene therapy applications

Waters Corporation introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.